While ADC development is accelerating rapidly, researchers need more sophisticated tools to evaluate ADC efficacy and tumor penetration in models that better reflect the complex tumor ...
Three-program alliance with Synaffix reflects SOTIO’s commitment to further broaden and advance innovative ADC pipeline ...
Combining the direct cytotoxic effects of antibody-drug conjugates (ADCs) with the immune-enhancing properties of immunostimulators represents a new therapeutic strategy that could not only eradicate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback